Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
Vaccines that elicit broadly cross-neutralizing antibodies, including antibodies that target the conserved stem of hemagglutinin (HA), are being developed as a strategy for next-generation influenza vaccines that protect against influenza across multiple years. However, efficient induction of cross-...
Main Authors: | Wei Wang, Russell Vassell, Hyo Sook Song, Qiong Chen, Paul W Keller, Swati Verma, Esmeralda Alvarado-Facundo, Hongquan Wan, Falko Schmeisser, Clement A Meseda, Jerry P Weir, Carol D Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0222436 |
Similar Items
-
Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
by: Falko Schmeisser, et al.
Published: (2015-01-01) -
Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.
by: Esmeralda Alvarado-Facundo, et al.
Published: (2016-01-01) -
Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
by: Swati Verma, et al.
Published: (2017-01-01) -
Development and Characterization of Monoclonal Antibodies against Hemagglutinins of Avian Influenza Viruses
by: Dih-Cheng Yu, et al.
Published: (2007) -
Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines.
by: Clement A Meseda, et al.
Published: (2016-01-01)